title: Update on adolescent immunization: pertussis, meningococcus, HPV, and the future.
abstract: Since January 2005, new vaccines against pertussis, meningococcal disease, and human papillomavirus (HPV) infection have been licensed. The target recipients are adolescents and preadolescents, who are at higher risk of these infections than other age groups. Routinely scheduled visits for 11- to 12-year-olds will allow for immunization against these and other diseases and give us an opportunity to provide anticipatory guidance against high-risk behaviors.
authors.affiliation: University of California, Los Angeles, USA. syeh@labiomed.org
authors.forename: Sylvia H
authors.initials: SH
authors.lastname: Yeh
authors.forename: Jay M
authors.initials: JM
authors.lastname: Lieberman
mesh_terms: D000293:Adolescent; D016497:Adolescent Health Services; D000367:Age Factors; D002648:Child; D006561:Herpes Simplex / Q000517:prevention & control; D006801:Humans; D017589:Immunization Programs; D008589:Meningococcal Infections / Q000517:prevention & control* / Q000635:transmission; D009345:Neisseria meningitidis; D030361:Papillomavirus Infections / Q000517:prevention & control* / Q000635:transmission; D018570:Risk Assessment; D012307:Risk Factors; D014917:Whooping Cough / Q000517:prevention & control*